Private Equity Dedicated to Longevity & Hormonal Health

Delivering exceptional outcomes for investors and the future of healthcare.

 

img-2
Explore Our Services – Explore Our Services –
img-6
img-5

About PEAL Capital

We Partner With Management Teams to Unlock Hidden Value

PEAL Capital is a Europe-based private equity firm focused on the longevity and hormones sector, investing across Western Europe, the UK, and North America. We take controlling or influential minority positions in mature lower-mid-cap businesses and deliver hands-on operational and financial support from acquisition through exit.

Year of
Experience

65+ years combined industry expertise
58 direct investments sourced and managed
2.27× average multiple on cost

Our Mission

To deliver strong, risk-adjusted returns by investing in secondary direct opportunities where our operational expertise and strategic oversight can unlock hidden value and accelerate growth.

Our Values

We believe in disciplined execution, full alignment with management teams, and long-term, sustainable growth. We are committed to integrity, transparency and building lasting partnerships.

img-5

Reasons to Choose Us

Why Investors Choose PEAL Capital

As the only private equity firm dedicated exclusively to the longevity and hormones sector, PEAL deploys a three-fund strategy that spans the entire supply chain, securing proprietary off-market opportunities and giving investors full-spectrum exposure.

N
Proprietary deal flow via trusted networks
N
Deep due diligence based on live portfolio data, not projections
N
Hands-on value creation through board-level involvement
N
Targeted exit strategies with reduced holding periods
N
Strong alignment with management and investors
N
Track record of consistent, risk-adjusted returns

AUM

Deal Size Range

Active Governance

Founder Experience

img-5

Meet Our Team

A Trusted Team With Decades of Investment and Operational Experience

img-35

Karen O'Mahony

Founder & Managing Partner

img-32

Brendan McDonagh

Chair of PEAL Capital Group

img-33

Tara Mandal

Partner & COO

img-5

News 

News and Insights From the PEAL Capital Group

DermaHub Launch

DermaHub Launch

On 1st November 2023, Derma Medical launched the world’s first e-learning hub for Aesthetics professionals. DermaHub will be the first of its kind to offer a subscription-based platform that will allow delegates to access the highest-quality online training from...

read more
TAIC Meet-Up

TAIC Meet-Up

Karen O'Mahony attends The Alternative Investment Club's Meet-Up, LONGEVITY: Not Only Living Longer but Better PEAL's Managing Partner, Karen O'Mahony, thoroughly enjoyed sharing her insights on Longevity alongside the panel at The Alternative Investment Club's...

read more
Private Equity International Operating Partners Forum

Private Equity International Operating Partners Forum

Karen O'Mahony spoke about building agility in the current economy and the next chapter of the value creation playbook at the PEI conference. At the Private Equity International Operating Partners Forum, Karen O'Mahony spoke about building agility in the current...

read more
EisnerAmper Engaging Alternatives Podcast

EisnerAmper Engaging Alternatives Podcast

Karen O'Mahony appears on the EisnerAmper Engaging Alternatives Podcast Elana Margulise Snydeerman from the EisnerAmper Engaging Alternatives Podcast invited PEAL's Managing Partner Karen O'Mahony to share her outlook for lower mid-cap private equity investing. They...

read more